Gene Screen Inc.- Dr. Lloyd Smith joins board of directors of Visible Genetics Inc.TORONTO--(BUSINESS WIRE)--March 16, 1995--Gene Screen Inc. (the "Company") is pleased to announce that Dr. Lloyd Smith Lloyd Smith was born December 12 1953. He is a native of Philadelphia, Pennsylvania. He played lead guitar in the funk band the Bar-Kays. His nickname in the band was "Luscious Lloyd". He also plays piano and other instruments. He is currently associated with a band called Hip-Soul. has joined the Board of Directors of Visible Genetics Inc. Dr. Smith invented the technology used in automated DNA sequencing DNA sequencing The determination of the sequence of nucleotides in a sample of DNA. and is known around the world for his work on gel electrophoresis. His pioneering patent forms the foundation of all existing automated DNA sequencers. Dr. Smith is an associate professor at the University of Wisconsin, and a member of both the Department of Energy Human Genome Coordinating Committee and the NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. (National Institutes of Health) National Centre for Human Genome Research Advisory Council. Dr. Smith has written over 70 scientific papers and has been granted 12 patents. The Company owns approximately 40 percent of Visible Genetics Inc., a private Toronto-based emerging innovative biotechnology company which is developing patentable products for high speed, low cost DNA sequencing for use in high volume clinical environments. The common shares of the Company are quoted for trading on the Canadian Dealing Network Canadian Dealing Network (CDN) The organized OTC market of Canada. Formerly known as the Canadian Over-the-Counter Automated Trading System (COATS), the CDN became a subsidiary of the Toronto Stock Exchange in 1991. (CDN (Content Delivery Network) A system of distributed content on a large intranet or the public Internet in which copies of content are replicated and cached throughout the network. ) under the symbol "GEAN". CONTACT: Sheldon Inwentash, (416) 941-8900 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion